| Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance ZC Nwosu, W Piorońska, N Battello, AD Zimmer, B Dewidar, M Han, ... EBioMedicine 54, 102699, 2020 | 43 | 2020 |
| Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF–PI3K pathway S Boyer, HJ Lee, N Steele, L Zhang, P Sajjakulnukit, A Andren, MH Ward, ... Elife 11, e73796, 2022 | 35 | 2022 |
| Uridine-derived ribose fuels glucose-restricted pancreatic cancer ZC Nwosu, MH Ward, P Sajjakulnukit, P Poudel, C Ragulan, S Kasperek, ... Nature, 1-8, 2023 | 30 | 2023 |
| The tetraspanin transmembrane protein CD53 mediates dyslipidemia and integrates inflammatory and metabolic signaling in hepatocytes CB Higgins, JA Adams, MH Ward, ZJ Greenberg, M Milewska, J Sun, ... Journal of Biological Chemistry 299 (2), 2023 | 4 | 2023 |
| Nutrient profiling reveals extracellular uridine as a fuel for pancreatic cancer through uridine phosphorylase 1 MH Ward, ZC Nwosu, P Poudel, S Kasperek, Z Tolstyka, RE Menjivar, ... bioRxiv, 2021.06. 07.447448, 2021 | 4 | 2021 |
| Uridine: as sweet as sugar for some cells? MH Ward, ZC Nwosu, CA Lyssiotis Cell Research, 1-2, 2023 | | 2023 |
| Abstract C36: A roadmap for targeting cysteine dependency in a subset of pancreatic cancer ZC Nwosu, MH Ward, P Sajjakulnukit, L Zhang, MP di Magliano, ... Cancer Research 79 (24 Supplement), C36-C36, 2019 | | 2019 |
| An interview with Professor Costas Lyssiotis C Lyssiotis, M Ward University of Michigan Undergraduate Research Journal 13, 2019 | | 2019 |
